Literature DB >> 17659680

Study of circumferential resection margin in patients with middle and lower rectal carcinoma.

Ze-Yu Wu1, Jin Wan, Jing-Hua Li, Gang Zhao, Lin Peng, Yuan Yao, Jia-Lin Du, Quan-Fang Liu, Zhi-Du Wang, Zhi-Ming Huang, Hua-Huan Lin.   

Abstract

AIM: To clarify the relationship between circumferential resection margin status and local and distant recurrence as well as survival of patients with middle and lower rectal carcinoma. The relationship between circumferential resection margin status and clinicopathologic characteristics of middle and lower rectal carcinoma was also evaluated.
METHODS: Cancer specimens from 56 patients with middle and lower rectal carcinoma who received total mesorectal excision at the Department of General Surgery of Guangdong Provincial People's Hospital were studied. A large slice technique was used to detect mesorectal metastasis and evaluate circumferential resection margin status.
RESULTS: Local recurrence occurred in 12.5% (7 of 56 cases) of patients with middle and lower rectal carcinoma. Distant recurrence occurred in 25% (14 of 56 cases) of patients with middle and lower rectal carcinoma. Twelve patients (21.4%) had positive circumferential resection margin. Local recurrence rate of patients with positive circumferential resection margin was 33.3% (4/12), whereas it was 6.8% (3/44) in those with negative circumferential resection margin (P = 0.014). Distant recurrence was observed in 50% (6/12) of patients with positive circumferential resection margin; conversely, it was 18.2% (8/44) in those with negative circumferential resection margin (P = 0.024). Kaplan-Meier survival analysis showed significant improvements in median survival (32.2 +/- 4.1 mo, 95% CI: 24.1-40.4 mo vs 23.0 +/- 3.5 mo, 95% CI: 16.2-29.8 mo) for circumferential resection margin-negative patients over circumferential resection margin-positive patients (log-rank, P < 0.05). 37% T(3) tumors examined were positive for circumferential resection margin, while only 0% T(1) tumors and 8.7% T(2) tumors were examined as circumferential resection margin. The difference between these three groups was statistically significant (P = 0.021). In 18 cancer specimens with tumor diameter >= 5 cm 7 (38.9%) were detected as positive circumferential resection margin, while in 38 cancer specimens with a tumor diameter of < 5 cm only 5 (13.2%) were positive for circumferential resection margin (P = 0.028).
CONCLUSION: Our findings indicate that circumferential resection margin involvement is significantly associated with depth of tumor invasion and tumor diameter. The circumferential resection margin status is an important predictor of local and distant recurrence as well as survival of patients with middle and lower rectal carcinoma.

Entities:  

Mesh:

Year:  2007        PMID: 17659680      PMCID: PMC4172721          DOI: 10.3748/wjg.v13.i24.3380

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

Review 1.  Locally recurrent rectal cancer: role of composite resection of extensive pelvic tumors with strategies for minimizing risk of recurrence.

Authors:  W J Temple; E B Saettler
Journal:  J Surg Oncol       Date:  2000-01       Impact factor: 3.454

2.  Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer.

Authors:  A Wibe; P R Rendedal; E Svensson; J Norstein; T J Eide; H E Myrvold; O Søreide
Journal:  Br J Surg       Date:  2002-03       Impact factor: 6.939

Review 3.  Total mesorectal excision for middle and lower rectal cancer: a single institution experience with 337 consecutive patients.

Authors:  Pompiliu Piso; Marc-Hendrik Dahlke; Petrit Mirena; Ursula Schmidt; Heiko Aselmann; Hans Juergen Schlitt; Rudolf Raab; Juergen Klempnauer
Journal:  J Surg Oncol       Date:  2004-06-01       Impact factor: 3.454

4.  Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?

Authors:  Suzannah Mawdsley; Rob Glynne-Jones; Juliet Grainger; Paul Richman; Andreas Makris; Mark Harrison; Richard Ashford; Richard A Harrison; Melanie Osborne; Jeremy I Livingstone; Peter MacDonald; Ian C Mitchell; John Meyrick-Thomas; John M A Northover; Alastair Windsor; Richard Novell; Marina Wallace
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-11-01       Impact factor: 7.038

5.  Comparison of circumferential margin involvement between restorative and nonrestorative resections for rectal cancer.

Authors:  P P Tekkis; A G Heriot; J Smith; M R Thompson; P Finan; J D Stamatakis
Journal:  Colorectal Dis       Date:  2005-07       Impact factor: 3.788

Review 6.  Locally recurrent rectal cancer.

Authors:  E Radice; R R Dozois
Journal:  Dig Surg       Date:  2001       Impact factor: 2.588

7.  Prognostic significance of circumferential margin involvement in rectal adenocarcinoma treated with preoperative chemoradiotherapy and low anterior resection.

Authors:  Pedro Luna-Pérez; Efraín Bustos-Cholico; Isabel Alvarado; Antonio Maffuz; Saúl Rodríguez-Ramírez; Marcos Gutiérrez de la Barrera; Sonia Labastida
Journal:  J Surg Oncol       Date:  2005-04-01       Impact factor: 3.454

8.  Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project.

Authors:  A L Martling; T Holm; L E Rutqvist; B J Moran; R J Heald; B Cedemark
Journal:  Lancet       Date:  2000-07-08       Impact factor: 79.321

9.  Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit.

Authors:  Iris D Nagtegaal; Corrie A M Marijnen; Elma Klein Kranenbarg; Cornelis J H van de Velde; J Han J M van Krieken
Journal:  Am J Surg Pathol       Date:  2002-03       Impact factor: 6.394

10.  Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.

Authors:  R J Heald; B J Moran; R D Ryall; R Sexton; J K MacFarlane
Journal:  Arch Surg       Date:  1998-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.